Recent studies have found that TIM‐4+ macrophages can promote an immunosuppressive tumor state, and inhibiting TIM‐4 has been shown to substantially enhance the effectiveness of anti‐PD‐1 therapy in mouse peritoneal carcinoma models.12 Here, TIMD4 is linked to peritoneal carcinoma.